Taking A Lesson From McDonald's
Executive Summary
Myrtle Potter and Andre Kay, the COO of Genentech and Head of Global Marketing and Sales for Novartis AG, respectively, oversee the commercial operations of companies that differ considerably in the scale and experience of their sales and marketing organizations. But at Windhover Information Inc.'s recent Marketing Pharmaceutical Innovation conference in Philadelphia, the two struck very similar tones in a session on global branding. Both spoke with urgency about the need for drug companies to adopt global strategies for quickly building and sustaining the value of major products in an increasingly competitive environment.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.